Inventor · disambiguated record
Martha Jo Whitehouse
Also filed as: WHITEHOUSE MARTHA J · WHITEHOUSE MARTHA JO
17 granted patents·22 pending applications·148 citations·filing 1999–2017
94Inventor score
Files withCHIRON CORP7NOVARTIS VACCINES & DIAGNOSTIC7UNEMORI ELAINE7NOVACEA INC6WHITEHOUSE MARTHA J3
Top patents by PatentIndex Score
39 records- 0194US8372809B2Method of treating dyspnea associated with acute heart failureCORTHERA INC·Filed 2011·Granted Feb 12, 2013·24 cites·16 claims
- 0291US7511019B2Method of treating coronary artery disease by administering FGF-4NOVARTIS VACCINES & DIAGNOSTIC·Filed 2005·Granted Mar 31, 2009·6 cites·11 claims
- 0390US8053411B2Method of treating dyspnea associated with acute heart failureCORTHERA INC·Filed 2009·Granted Nov 8, 2011·12 cites·38 claims
- 0485US8415301B2Method of treating dyspnea associated with acute heart failure by administering H2 relaxinUNEMORI ELAINE·Filed 2009·Granted Apr 9, 2013·6 cites·15 claims
- 0585US7858584B2Angiogenically effective unit dose of FGF and method of administeringNOVARTIS VACCINES & DIAGNOSTIC·Filed 2009·Granted Dec 28, 2010·2 cites·19 claims
- 0681US6451303B1Method of treating coronary artery disease by administering a recombinant FGFCHIRON CORP·Filed 1999·Granted Sep 17, 2002·35 cites·7 claims
- 0780US7541333B2Angiogenically effective unit dose of FGF-2 and method of useNOVARTIS VACCINES & DIAGNOSTIC·Filed 2006·Granted Jun 2, 2009·3 cites·16 claims
- 0878US9066916B2Method of treating neurohormonal imbalanceNOVARTIS AG·Filed 2013·Granted Jun 30, 2015·2 cites·9 claims
- 0977US9205132B2Method of lowering mortalityUNEMORI ELAINE·Filed 2013·Granted Dec 8, 2015·2 cites·8 claims
- 1077US6440934B1Angiogenically effective unit dose of FGF-2 and method of useCHIRON CORP·Filed 1999·Granted Aug 27, 2002·46 cites·58 claims
- 1174US7112560B2Angiogenically effective unit dose of FGF-2 and method of useCHIRON CORP·Filed 2004·Granted Sep 26, 2006·5 cites·18 claims
- 1272US8796211B2Method of treating coronary artery disease FGF-2WHITEHOUSE MARTHA JO·Filed 2011·Granted Aug 5, 2014·1 cites·28 claims
- 1370US9149507B2Method of treating coronary artery disease by administering FGF-9NOVARTIS VACCINES & DIAGNOSTIC·Filed 2013·Granted Oct 6, 2015·0 cites·11 claims
- 1470US7186407B2Methods and compositions for the treatment of peripheral artery diseaseCHIRON CORP·Filed 2004·Granted Mar 6, 2007·3 cites·77 claims
- 1566US8618052B2Method of treating coronary artery disease by administering FGF-5WHITEHOUSE MARTHA J·Filed 2010·Granted Dec 31, 2013·1 cites·11 claims
- 1666US2018221446A1Angiogenically Effective Unit Dose Of FGF And Method Of AdministeringNOVARTIS VACCINES & DIAGNOSTICS INC·Filed 2017·Application pending·0 cites
- 1761US7541337B2Methods and compositions for the treatment of peripheral artery diseaseNOVARTIS VACCINES & DIAGNOSTIC·Filed 2007·Granted Jun 2, 2009·0 cites·26 claims
- 1861US2011144019A1Method of treating chronic heart failureUNEMORI ELAINE·Filed 2009·Application pending·0 cites
- 1960US2017151311A1Method of treating dyspnea associated with acute heart failureUNEMORI ELAINE·Filed 2017·Application pending·0 cites
- 2060US2005101576A1Methods of using vitamin D compounds in the treatment of myelodysplastic syndromesNOVACEA INC·Filed 2004·Application pending·0 cites
- 2158US9579363B2Method of lowering mortalityUNEMORI ELAINE·Filed 2015·Granted Feb 28, 2017·0 cites·10 claims
- 2258US2003166550A1Angiogenically effective unit dose of FGF-2 and method of useCHIRON CORP·Filed 2002·Application pending·0 cites
- 2358US2014349932A1Angiogenically effective unit dose of fgf-2 and method of useNOVARTIS VACCINES & DIAGNOSTIC·Filed 2014·Application pending·0 cites
- 2457US2007027120A1Methods of using vitamin D compounds in the treatment of myelodysplastic syndromesWHITEHOUSE MARTHA J·Filed 2006·Application pending·0 cites
- 2556US2008242648A1COMBINATION OF ERa+ LIGANDS AND HISTONE DEACETYLASE INHIBITORS FOR THE TREATMENT OF CANCERSYNDAX PHARMACEUTICALS INC A C·Filed 2007·Application pending·0 cites
- 2653US2007148205A1Prevention of Arterial Restenosis with Active Vitamin D CompoundsWHITEHOUSE MARTHA J·Filed 2006·Application pending·0 cites
- 2753US2014005112A1Method of treating chronic heart failure by administering relaxinUNEMORI ELAINE·Filed 2013·Application pending·0 cites
- 2852US2016120943A1Angiogenically effective unit dose of fgf and method of administeringNOVARTIS VACCINES & DIAGNOSTIC·Filed 2015·Application pending·0 cites
- 2952US2002165160A1Angiogenically effective unit dose of FGF and method of administeringCHIRON CORP·Filed 2002·Application pending·0 cites
- 3051US2007142339A1Prevention of arterial restenosis with active vitamin d compoundsNOVACEA INC·Filed 2005·Application pending·0 cites
- 3149US2002115603A1Methods and compositions for the treatment of peripheral artery diseaseCHIRON CORP·Filed 2001·Application pending·0 cites
- 3248US2002072489A1Angiogenically effective unit dose of FGF-2 and method of useFiled 2001·Application pending·0 cites
- 3347US2016287672A1Method of treating chronic heart failure by administering relaxinUNEMORI ELAINE·Filed 2016·Application pending·0 cites
- 3447US2007003614A1Pharmaceutical compositions comprising active vitamin D compoundsCHEN ANDREW X·Filed 2006·Application pending·0 cites
- 3546US2002032153A1Methods and compositions for the treatment and prevention of erectile dysfunctionFiled 2001·Application pending·0 cites
- 3643US2006178351A1Treatment of immune-mediated disorders with active vitamin D compounds alone or in combination with other therapeutic agentsNOVACEA INC·Filed 2005·Application pending·0 cites
- 3743US2003191093A1Pharmaceutical compositions comprising active vitamin D compoundsNOVACEA INC·Filed 2002·Application pending·0 cites
- 3843US2006172014A1Treatment of lung cancer with active vitamin D compounds in combination with other treatmentsNOVACEA INC·Filed 2005·Application pending·0 cites
- 3941US2005026877A1Pharmaceutical compositions comprising active vitamin D compoundsNOVACEA INC·Filed 2004·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →